Cargando…

Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies

Trace amine-associated receptor 1 (TAAR1) has emerged as a promising therapeutic target for neuropsychiatric disorders due to its ability to modulate monoaminergic and glutamatergic neurotransmission. In particular, agonist compounds have generated interest as potential treatments for schizophrenia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dedic, Nina, Dworak, Heather, Zeni, Courtney, Rutigliano, Grazia, Howes, Oliver D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704992/ https://www.ncbi.nlm.nih.gov/pubmed/34947997 http://dx.doi.org/10.3390/ijms222413185

Ejemplares similares

Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia
por: Achtyes, Eric D., et al.
Publicado: (2023)

Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia
por: Heffernan, Michele L. R., et al.
Publicado: (2021)

In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT(1A) Receptor Agonist for the Treatment of Schizophrenia
por: Xiao, Guangqing, et al.
Publicado: (2022)

Effect of TAAR1/5-HT(1A) agonist SEP-363856 on REM sleep in humans
por: Hopkins, Seth C., et al.
Publicado: (2021)

The Case for TAAR1 as a Modulator of Central Nervous System Function
por: Rutigliano, Grazia, et al.
Publicado: (2018)

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP-363856
por: Saarinen, Marcus, et al.
Publicado: (2022)

Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP- 363856
por: Saarinen, Marcus, et al.
Publicado: (2022)

Biological evaluation and in silico studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatment
por: Wang, Yunjie, et al.
Publicado: (2023)

Structural and Functional Evolution of the Trace Amine-Associated Receptors TAAR3, TAAR4 and TAAR5 in Primates
por: Stäubert, Claudia, et al.
Publicado: (2010)

T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
por: Polini, Beatrice, et al.
Publicado: (2023)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
por: Bellusci, Lorenza, et al.
Publicado: (2017)

The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice
por: Ren, Xia, et al.
Publicado: (2022)

Identification and characterization of cichlid TAAR genes and comparison with other teleost TAAR repertoires
por: Azzouzi, Naoual, et al.
Publicado: (2015)

Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors
por: Glyakina, Anna V., et al.
Publicado: (2021)

Dynamic Stability of Volatile Organic Compounds in Respiratory Air in Schizophrenic Patients and Its Potential Predicting Efficacy of TAAR Agonists
por: Held, Anna, et al.
Publicado: (2023)

Analysis of Human TAAR8 and Murine Taar8b Mediated Signaling Pathways and Expression Profile
por: Mühlhaus, Jessica, et al.
Publicado: (2014)

Behavioral Effects of a Potential Novel TAAR1 Antagonist
por: Lam, Vincent M., et al.
Publicado: (2018)

Taare Zameen Par and dyslexic savants
por: Chakravarty, Ambar
Publicado: (2009)

Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397
por: Espinoza, Stefano, et al.
Publicado: (2018)

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics
por: Ågren, Richard, et al.
Publicado: (2023)

TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg
por: Liu, Jian-Feng, et al.
Publicado: (2018)

Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays
por: Cichero, Elena, et al.
Publicado: (2023)

S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?
por: Breier, Alan, et al.
Publicado: (2020)

Improving Efficiency and Equity in Early Autism Evaluations: The (S)TAAR Model
por: Brinster, Meredith I., et al.
Publicado: (2022)

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence
por: Matheson, Justin, et al.
Publicado: (2020)

Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERS
por: Hopkins, Seth C., et al.
Publicado: (2021)

Investigation of Naturally Occurring Single-Nucleotide Variants in Human TAAR1
por: Mühlhaus, Jessica, et al.
Publicado: (2017)

Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers
por: Fleischer, Lisa M., et al.
Publicado: (2018)

TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
por: Barnes, David A., et al.
Publicado: (2021)

Preclinical characterization of AMPA receptor potentiator TAK‐137 as a therapeutic drug for schizophrenia
por: Tanaka, Maiko, et al.
Publicado: (2019)

Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies
por: Francesconi, Valeria, et al.
Publicado: (2020)

Human Trace Amine-Associated Receptor TAAR5 Can Be Activated by Trimethylamine
por: Wallrabenstein, Ivonne, et al.
Publicado: (2013)

Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward
por: Moore, Catherine F., et al.
Publicado: (2018)

Pattern of TAAR5 Expression in the Human Brain Based on Transcriptome Datasets Analysis
por: Vaganova, Anastasia N., et al.
Publicado: (2021)

Role of the trace amine associated receptor 5 (TAAR5) in the sensorimotor functions
por: Kalinina, D. S., et al.
Publicado: (2021)

Deregulation of Trace Amine-Associated Receptors (TAAR) Expression and Signaling Mode in Melanoma
por: Vaganova, Anastasia N., et al.
Publicado: (2022)

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
por: Tremmel, Eileen, et al.
Publicado: (2019)

Functional evolution of the trace amine associated receptors in mammals and the loss of TAAR1 in dogs
por: Vallender, Eric J, et al.
Publicado: (2010)

Timberol® Inhibits TAAR5-Mediated Responses to Trimethylamine and Influences the Olfactory Threshold in Humans
por: Wallrabenstein, Ivonne, et al.
Publicado: (2015)

Olfactory function in the trace amine-associated receptor family (TAARs) evolved twice independently
por: Dieris, Milan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_usk2ov50bourdt1lejr2vag5an